Crossmark

Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian pediatric patients: Real world experience

Crossref DOI link: https://doi.org/10.1016/j.gastre.2024.04.010

Published Print: 2024-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Parra-Izquierdo, Viviana

Frías-Ordoñez, Juan Sebastián

Cuadros, Carlos

Vargas, Melquicedec

Vera Chamorro, José Fernando

Romero Sanchez, Consuelo

Flórez-Sarmiento, Cristian
License Information

Text and Data Mining valid from 2024-06-01

Text and Data Mining valid from 2024-06-01

stm-asf valid from 2024-06-01

stm-asf valid from 2024-06-01

stm-asf valid from 2024-06-01

stm-asf valid from 2024-06-01

stm-asf valid from 2024-06-01
More Information

This article is maintained by: Elsevier

Article Title: Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian pediatric patients: Real world experience

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2024.04.010

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2023.09.013

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.